HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavir. [electronic resource]
Producer: 20150810Description: 243-8 p. digitalISSN:- 1460-2091
- Female
- Genotype
- HIV Infections -- drug therapy
- HIV Protease -- genetics
- HIV Protease Inhibitors -- therapeutic use
- HIV-1 -- drug effects
- Humans
- Lopinavir -- therapeutic use
- Male
- Microbial Sensitivity Tests
- Ritonavir -- therapeutic use
- Sequence Analysis, DNA
- Treatment Failure
- gag Gene Products, Human Immunodeficiency Virus -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.